금정제약(주)

02R&D

제품정보

R&D

연구분야 파이프라인 논문

R&D 논문

논문

Structural basis of the oncogenic KRAS mutant and GJ101 complex, Biochemical and Biophysical Research Communications. (2023)

조회수 296

이전글 Structural study of novel vaccinia virus E3L and dsRNA-dependent proteinkinase complex, Biochemical and Biophysical Research Communications. (2023)
다음글 DED Interaction of FADD and Caspase-8 in the Induction of Apoptotic Cell Death, J Microbiol Biotechnol. (2022)

개인정보처리방침 이메일무단수집거부

회사명 : 금정제약(주)

대표 : 정미숙

주소 : 서울특별시 영등포구 국회대로66길 23

TEL : 02-784-2544

FAX : 02-784-2545

Copyright© 금정제약(주). All Rights Reserved.